...to FDA this year (see "Filgotinib Hits More RA Endpoints" ). GeneCentric acquires Select ImmunoGenomics GeneCentric Therapeutics Inc....
...development capabilities. Financial terms were undisclosed. Hongjiang Li and Elizabeth S. Eaton, Staff Writers filgotinib (GLPG0634, GS-6034) Galapagos N.V. GeneCentric Therapeutics Inc. Gilead...

...Yarra Therapeutics LLC, a rare disease subsidiary of Array Biopharma Inc. (NASDAQ:ARRY). Precision cancer company GeneCentric Therapeutics Inc....

...Smith as president. He was president and COO of Celgene Corp. (NASDAQ:CELG). Precision cancer company GeneCentric Therapeutics Inc....

...will be primarily the lead on the deal. The companies declined to disclose further details. GeneCentric Diagnostics...
...Inc. , Durham, N.C. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer Nora Weintraub Opdivo Bristol-Myers Squibb Co. GeneCentric Diagnostics...

...American Society of Clinical Oncology (ASCO), Alexandria, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GeneCentric Diagnostics...

...final validation testing of the Lung Subtype Platform technology. The company declined to provide details. GeneCentric Diagnostics...

...Molecular diagnostic company GeneCentric Diagnostics Inc. (Durham, N.C.) said it raised $250,000 from Hatteras Venture Partners last...